Non‐small cell lung cancer (NSCLC) accounts for approximately one in five cancer‐related
deaths, and management requires increasingly complex decision making by health care …

Background Accurate diagnosis and staging are crucial to ensure uniform allocation to the
optimal treatment methods for non-small cell lung cancer (NSCLC) patients, but may differ …

The complexity of lung cancer care mandates interaction between clinicians with different
skill sets and practice cultures in the routine delivery of care. Using team science principles …

Introduction The Institute of Medicine, the American Society of Clinical Oncology, and the
European Society of Medical Oncology promote a multidisciplinary approach for the …

Major advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC) have
resulted in a sharp decline in associated mortality rates, thereby propelling NSCLC to the …

Globally, lung cancer is the leading cause of cancer-related mortality among both men and
women, and while mortality associated with the disease has demon strated relative stability …

Historically, a simple approach to the treatment of non-small-cell lung cancer (nsclc) was
applicable to nearly all patients. Recently, a more complex treatment algorithm has …

The current third consensus on the systemic treatment of non-small-cell lung cancer
(NSCLC) builds upon and updates similar publications on the subject by the Central …

Non-small cell lung cancer (NSCLC) has historically been associated with a poor prognosis
and low 5-year survival, but the use of targeted therapies in NSCLC has improved patient …

Background and objective While multidisciplinary team (MDT) care in lung cancer is widely
practiced, there are few guidelines for MDT on best data collection strategies. MDT meetings …